Alemtuzumab: a review of its use in patients with relapsing multiple sclerosis.

Abstract

Alemtuzumab (Lemtrada™) is a humanized therapeutic monoclonal antibody, which has been approved for use in patients with B-cell chronic lymphocytic leukaemia for several years, and has recently become approved in the EU and several other countries for use in adult patients with active relapsing-remitting multiple sclerosis. This article reviews the… (More)
DOI: 10.1007/s40265-014-0195-7

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Statistics

0102030201520162017
Citations per Year

Citation Velocity: 7

Averaging 7 citations per year over the last 3 years.

Learn more about how we calculate this metric in our FAQ.

Slides referencing similar topics